Shaanxi Panlong Pharmaceutical Group Co., Ltd. (SHE:002864)

China · Delayed Price · Currency is CNY

21.10

-0.76 (-3.48%)

Sep 10, 2026, 3:04 PM CST

Market Cap	3.01B -5.7%
Revenue (ttm)	989.42M -9.4%
Net Income	78.52M -35.0%
EPS	0.58 -34.6%
Shares Out	137.68M
PE Ratio	37.81
Forward PE	n/a
Dividend	0.27 (1.28%)
Ex-Dividend Date	Jul 22, 2026

Volume	2,684,110
Open	21.41
Previous Close	21.86
Day's Range	20.95 - 21.78
52-Week Range	19.00 - 32.99
Beta	-0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHE:002864

Shaanxi Panlong Pharmaceutical Group Co., Ltd. researches and develops, produces, and sells Chinese patent medicines and traditional Chinese medicine formula granules in China. The company offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. It also offers health food, health products, functional health ... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1997

Employees 926

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002864

Full Company Profile

Financial Performance

In 2025, SHE:002864's revenue was 1.14 billion, an increase of 17.15% compared to the previous year's 973.86 million. Earnings were 96.28 million, a decrease of -19.95%.

Financial Statements